Phaos Technology Holdings (Cayman) (POAS) Total Non-Current Liabilities (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Total Non-Current Liabilities came in at $46418.3 in Q4 2025, down 38.61% on a QoQ basis from $75610.0 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Total Non-Current Liabilities data on file, last reported at $46418.3 in Q4 2025.
- Quarterly Total Non-Current Liabilities changed N/A year-over-year to $46418.3 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $46418.3 (changed N/A YoY) and the FY2025 annual result came in at $75679.3, down 53.53% from the prior year.
- Total Non-Current Liabilities retreated to $46418.3 in Q4 2025, from $75610.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $162855.3 in Q2 2024 to a low of $46418.3 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.12 Mn | 4.08 Mn | - | 46,418.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 46,418.32 |
| Apr 30, 2025 | 75,610.04 |
| Apr 30, 2024 | 162,855.32 |